These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9425929)

  • 61. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
    Takenaka O; Horie T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of hepatic blood flow on taurocholate extraction by the isolated perfused rat liver.
    Pries JM; Staples AB; Hanson RF
    J Lab Clin Med; 1981 Mar; 97(3):412-7. PubMed ID: 7462773
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kinetics of taurocholate uptake by the perfused rat liver.
    Reichen J; Paumgartner G
    Gastroenterology; 1975 Jan; 68(1):132-6. PubMed ID: 1090476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
    Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of route of input on the hepatic disposition of diazepam.
    Sahin S; Rowland M
    J Pharmacol Exp Ther; 2000 Nov; 295(2):836-43. PubMed ID: 11046126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism of flupyrazofos in the isolated perfused rat liver.
    Jeong CK; Lee HY; Kim SB; Choi SJ; Kim JH; Kim K; Han SS; Lee HS
    Pest Manag Sci; 2001 May; 57(5):427-31. PubMed ID: 11374159
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
    Sabordo L; Sallustio BC; Evans AM; Nation RL
    J Pharmacol Exp Ther; 2000 Oct; 295(1):44-50. PubMed ID: 10991959
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Disposition of enalapril and its diacid metabolite, enalaprilat, in a perfused rat liver preparation. Presence of a diffusional barrier for enalaprilat into hepatocytes.
    Pang KS; Cherry WF; Terrell JA; Ulm EH
    Drug Metab Dispos; 1984; 12(3):309-13. PubMed ID: 6145558
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molybdate depletes hepatic 3-phosphoadenosine 5-phosphosulfate and impairs the sulfation of acetaminophen in rats.
    Oguro T; Gregus Z; Madhu C; Liu L; Klaassen CD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1145-51. PubMed ID: 7932164
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver.
    Hung DY; Chang P; Cheung K; Winterford C; Roberts MS
    Hepatology; 2002 Nov; 36(5):1180-9. PubMed ID: 12395328
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatic uptake and metabolism of benzoate: a multiple indicator dilution, perfused rat liver study.
    Schwab AJ; Tao L; Yoshimura T; Simard A; Barker F; Pang KS
    Am J Physiol Gastrointest Liver Physiol; 2001 Jun; 280(6):G1124-36. PubMed ID: 11352805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.
    Geng W; Pang KS
    J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An optimized model for rat liver perfusion studies.
    Cheung K; Hickman PE; Potter JM; Walker NI; Jericho M; Haslam R; Roberts MS
    J Surg Res; 1996 Nov; 66(1):81-9. PubMed ID: 8954836
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hydrolysis of 4-methylumbelliferyl sulfate in periportal and pericentral areas of the liver lobule.
    Anundi I; Kauffman FC; el-Mouelhi M; Thurman RG
    Arch Toxicol; 1987; 60(1-3):69-72. PubMed ID: 3619646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dose-dependent intestinal and hepatic glucuronidation and sulfatation of P-nitrophenol in the rat.
    Rafiei A; Bojcsev S; Fischer E
    Acta Physiol Hung; 1996; 84(3):333-5. PubMed ID: 9219629
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.